Safety of degludec versus glargine in type 2 diabetes

Steven P. Marso; John B. Buse

doi:10.1056/NEJMc1712575

Safety of degludec versus glargine in type 2 diabetes

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1995-1996
Number of pages	2
Journal	New England Journal of Medicine
Volume	377
Issue number	20
DOIs	https://doi.org/10.1056/NEJMc1712575
State	Published - Nov 16 2017

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMc1712575

Cite this

@article{4e8bf7f062014231b1b555c028a45729,

title = "Safety of degludec versus glargine in type 2 diabetes",

author = "Marso, {Steven P.} and Buse, {John B.}",

year = "2017",

month = nov,

day = "16",

doi = "10.1056/NEJMc1712575",

language = "English (US)",

volume = "377",

pages = "1995--1996",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "20",

}

TY - JOUR

T1 - Safety of degludec versus glargine in type 2 diabetes

AU - Marso, Steven P.

AU - Buse, John B.

PY - 2017/11/16

Y1 - 2017/11/16

UR - http://www.scopus.com/inward/record.url?scp=85033772095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033772095&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1712575

DO - 10.1056/NEJMc1712575

M3 - Letter

C2 - 29141162

AN - SCOPUS:85033772095

SN - 0028-4793

VL - 377

SP - 1995

EP - 1996

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 20

ER -

Safety of degludec versus glargine in type 2 diabetes

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this